Leidos (LDOS) director boosts deferred stake with 305 dividend-equivalent shares

Rhea-AI Filing Summary

Leidos Holdings director reports additional stock units from dividend equivalents. A Leidos Holdings, Inc. (LDOS) director filed a statement of beneficial ownership covering a transaction dated 12/31/2025. The filing shows an acquisition of 305.0167 shares of common stock at a price of $0, credited through dividend equivalent rights under a Key Executive Stock Deferral Plan. After this transaction, the director beneficially owned 128,639.4827 shares indirectly through the deferral plan and 91,360 shares directly. The dividend equivalent rights noted in the explanation indicate the award reflects dividends on previously deferred equity, rather than an open-market stock purchase.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRAEMER HARRY M JANSEN JR

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/31/2025		A		305.0167(1)	A	$0	128,639.4827	I	By Key Executive Stock Deferral Plan
Common Stock								91,360	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Dividend equivalent rights.

Remarks:

	/s/ Ramune M. Kligys by PoA of Harry M. Jansen Kraemer, Jr.	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Leidos Holdings (LDOS) report in this Form 4?

The Form 4 reports that a Leidos Holdings, Inc. director acquired 305.0167 shares of common stock on 12/31/2025 at a price of $0, credited under a Key Executive Stock Deferral Plan.

How many Leidos (LDOS) shares does the director own after this transaction?

Following the reported transaction, the director beneficially owns 128,639.4827 shares indirectly through the Key Executive Stock Deferral Plan and 91,360 shares directly of Leidos common stock.

What is the nature of the 305.0167 Leidos (LDOS) shares reported as acquired?

The 305.0167 Leidos common shares are described as dividend equivalent rights, meaning they were credited as equivalents to dividends on previously deferred equity rather than purchased for cash.

Is the reporting person in the Leidos (LDOS) Form 4 an officer or a director?

The filing identifies the reporting person’s relationship to Leidos Holdings, Inc. as a Director, with no officer title indicated.

How are the indirect Leidos (LDOS) holdings structured for this director?

The indirect holdings of 128,639.4827 shares are held through a Key Executive Stock Deferral Plan, as indicated in the ownership table.

Does this Leidos (LDOS) Form 4 include any derivative securities transactions?

The section for derivative securities is present, but the provided content shows no specific derivative securities acquired or disposed of in this filing.